亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Aberrant Regional DNA Hypermethylation As a Preventive and Therapeutic Target for Adult T-Cell Leukemia-Lymphoma

脱甲基剂 DNA甲基化 白血病 表观遗传学 生物 癌症研究 淋巴瘤 癌变 免疫学 T细胞白血病 CpG站点 人嗜T淋巴细胞病毒1型 癌症 病毒学 基因 遗传学 基因表达
作者
Tatsuro Watanabe,Hiroshi Ureshino,Yuki Kurahashi,Yuki Fukuda‐Kurahashi,Satoshi Yamashita,Toshikazu Ushijima,Seiji Okada,Eisaburo Sueoka,Shinya Kimura
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 4175-4175 被引量:1
标识
DOI:10.1182/blood-2018-99-117536
摘要

Abstract Aberrant DNA methylation profiles in various types of cancer have highlighted the importance of DNA methylation in human carcinogenesis and opened the prospect of targeting aberrant DNA methylation with demethylating agents as a therapy for cancer. Adult T-cell leukemia-lymphoma (ATL) is an aggressive hematological malignancy derived from CD4 (+) T-cells transformed by human T-cell lymphotropic virus-1 (HTLV-1). Although it has been estimated that 20 million people are infected with HTLV-1 worldwide, most HTLV-1 infected individuals have no symptoms and only 3-7% of HTLV-1 positive carriers develop ATL in their life time. HTLV-1 infected cells undergo multistep leukemogenesis and there are four clinical subtypes of ATL, smoldering type, chronic type, acute type, and lymphoma type. It takes several decades to acquire aggressive phenotypes through the accumulation of genetic and epigenetic abnormalities. In this study, we aimed to elucidate the contribution of aberrant DNA methylation to ATL leukemogenesis and the anti-ATL effects of DNA demethylating agents. Since the expression profiles of CADM1 and CD7 in CD4 (+) T-cells reflect ATL disease progression, fractions of HTLV-1 infected cells and normal T-cells were isolated from ATL patients, HTLV-1 carriers, and healthy volunteers using the expression statuses of CADM1 and CD7. Comprehensive genome-wide profiling of DNA methylation was performed by quantitative array-based methylation analysis at the single-CpG-site level using the Infinium HumanMethylation450 BeadChip array. Anti-ATL effects of four DNA demethylating agents were investigated in in vitro experiments using ATL-related cell lines and a xenograft mouse model. Unsupervised hierarchical clustering analysis was first conducted using the DNA methylation profiles of 20,000 CpG probes, which were randomly picked from 470,870 probes. Global DNA hypomethylation was detected in HTLV-1 infected cells at the asymptomatic carrier stage. To identify differentially methylated positions (DMPs) that specifically reflect ATL disease status, the DNA methylation profiles of a normal cell subpopulation were compared with those of a HTLV-1 infected subpopulation. We identified 12,025 hypermethylated and 33,581 hypomethylated DMPs that were specific to the HTLV-1 infected subpopulation. Importantly, the methylation profiles of hypermethylated DMPs, but not those of hypomethylated DMPs, were different between the aggressive and indolent types of ATL and could be used to distinguish them. Therefore, we next extracted and analyzed 1,207 hypermethylated CpG sites located in TSS200 CpG islands (CGIs) in hypermethylated DMPs, since TSS200 CGIs are widely recognized to regulate gene expression in a methylation dependent manner. We found the DNA methylation profiles of 1,207 probes tended to correlate with ATL disease status. Since regional DNA hypermethylation appears to be associated with ATL disease progression, we tested the anti-leukemia activities of two novel decitabine prodrugs, OR-21 and OR-12, and compared their efficacies with those of clinically available AZA and DAC. OR-21 and OR-12 showed enhanced oral bioavailability and sustained release of decitabine and decitabine 5'-monophosphate, respectively. In ATL-related T-cell lines cultured in the presence of each DNA demethylating compound, DAC and OR-21 significantly suppressed cell growth and decreased DNA methylation at LINE-1 repeat regions, which are used as a biomarker for the monitoring of global changes in DNA methylation. To establish a xenograft mouse model, cells of the HTLV-1-transformed T-cell line, MT-2, were inoculated into the subcutaneous tissue of immunodeficient Balb/c Rag-2-/- Jak3-/- mice, which lack mature T and B lymphocytes and NK cells. A visible tumor appeared 10 days after inoculation and DAC or OR-21 was injected intraperitoneally twice a week, because they were rapidly degraded in the stomach acidic environment and could not be administered orally. The AUC-guided dosing of OR21 (3.39mg/kg) suppressed tumor growth, which was comparable with that obtained with 1.25 mg/kg DAC, while OR21 showed less hematotoxicity than DAC. Disclosures Watanabe: OHARA Pharmaceutical Co., Ltd.: Research Funding. Ureshino:OHARA Pharmaceutical Co., Ltd.: Research Funding. Kurahashi:OHARA Pharmaceutical Co., Ltd.: Employment. Fukuda-Kurahashi:OHARA Pharmaceutical Co., Ltd.: Employment. Kimura:OHARA Pharmaceutical Co., Ltd.: Research Funding.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冷艳千柳完成签到,获得积分10
13秒前
22秒前
感性的念之完成签到,获得积分10
41秒前
53秒前
1分钟前
坚定百褶裙完成签到,获得积分10
1分钟前
1分钟前
漂亮的幻枫完成签到,获得积分10
1分钟前
Crisp完成签到 ,获得积分0
1分钟前
枕月完成签到,获得积分10
1分钟前
精明凝海发布了新的文献求助10
1分钟前
悲凉的丝完成签到,获得积分10
1分钟前
2分钟前
饱满飞绿完成签到,获得积分10
2分钟前
ajing发布了新的文献求助10
2分钟前
朴实水云完成签到,获得积分10
2分钟前
2分钟前
2分钟前
枕月发布了新的文献求助10
2分钟前
生动的依白完成签到,获得积分10
2分钟前
AnYX完成签到 ,获得积分10
2分钟前
震动的醉蓝完成签到,获得积分10
2分钟前
3分钟前
Prof.Z发布了新的文献求助80
3分钟前
3分钟前
忧心的棒球完成签到,获得积分10
3分钟前
3分钟前
万霖完成签到,获得积分10
3分钟前
3分钟前
曾经凌萱发布了新的文献求助10
3分钟前
愉快的书桃完成签到,获得积分10
3分钟前
3分钟前
3分钟前
3分钟前
香蕉觅云的应助被曾经凌萱采纳,获得10
3分钟前
慢读文献完成签到,获得积分10
4分钟前
yuxia完成签到 ,获得积分10
4分钟前
老实的石头完成签到,获得积分10
4分钟前
明亮的藏鸟完成签到,获得积分10
4分钟前
舒服的荧完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179896
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808343
捐赠科研通 7775692
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557334
邀请新用户注册赠送积分活动 2478881